{"id":"W4392284387","doi":"10.1016/j.jaci.2024.01.028","title":"Dupilumab in patients with chronic spontaneous urticaria (LIBERTY-CSU CUPID): Two randomized, double-blind, placebo-controlled, phase 3 trials","year":2024,"lang":"en","type":"article","venue":"Journal of Allergy and Clinical Immunology","topic":"Urticaria and Related Conditions","field":"Medicine","cited_by":143,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University Health Centre","funders":"Regeneron Pharmaceuticals; Sanofi; Amgen; Celldex Therapeutics; Genentech; AstraZeneca","keywords":"Placebo; Dupilumab; Chronic urticaria; Medicine; Double blind; Randomized controlled trial; Phase (matter); Dermatology; Internal medicine; Alternative medicine; Atopic dermatitis; Pathology; Physics","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005587675,0.001822028,0.00426361,0.0005576818,0.0008183873,0.001780675,0.001131166,0.003165084,0.004606379],"category_scores_gemma":[0.004717438,0.0009272228,0.003582891,0.0008186704,0.001236053,0.001145761,0.0005592038,0.002207294,0.0005514614],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0012333,"about_ca_system_score_gemma":0.001786947,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001202426,"about_ca_topic_score_gemma":0.003286077,"domain_scores_codex":[0.9977387,0.001203791,0.0002302061,0.0003751011,0.0002177674,0.0002344503],"domain_scores_gemma":[0.9974566,0.0007924586,0.0008582935,0.0001885831,0.000220084,0.0004839411],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9632195,0.003364023,0.0007362284,0.003644606,0.003255252,0.00005997968,0.00009950213,0.0001256054,0.001916321,0.0001145595,0.001122907,0.02234153],"study_design_scores_gemma":[0.9792989,0.01779719,0.001098351,0.00009177394,0.0008350098,0.00004072207,0.00001220338,0.00008600177,0.0001407639,0.00005357396,0.0005348738,0.00001046234],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8944438,0.07755066,0.001779734,0.002286929,0.001390882,0.01577046,0.003015213,0.0003137869,0.003448646],"genre_scores_gemma":[0.9552862,0.01732585,0.003692659,0.003351042,0.0008810177,0.0159868,0.001686063,0.00003687954,0.001753454],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005587675,"threshold_uncertainty_score":0.02955085,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02650355750841208,"score_gpt":0.3545363251829817,"score_spread":0.3280327676745696,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}